A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia

NCT00249223 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

641

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Psychotic Disorders

Interventions

DRUG: Risperidone Long acting injectable

Sponsor

Janssen Pharmaceutica N.V., Belgium